key: cord-0736410-gux6d2sm authors: Kowada, Akiko title: Greater public health impact of COVID-19 antigen detection tests date: 2021-03-24 journal: BMC Med DOI: 10.1186/s12916-021-01956-z sha: 83fd094324359031e7bfee72656f6b914403e4f8 doc_id: 736410 cord_uid: gux6d2sm nan expected to play an increasingly important role in the early diagnosis of SARS-CoV-2 infection and will be more useful in hospitals, communities, and airports around the world. Ricks et al. now report in BMC Medicine greater healthcare cost-saving and health outcomes of antigen detection rapid diagnostic tests compared to nucleic acid tests for symptomatic persons [4] . The main outcomes in the study are the health system costs and health impacts (deaths averted and infectious days isolated). Antigendetection rapid diagnostic test-led strategy is compared to a strategy based on nucleic acid tests and clinical judgment. Two important case scenarios are considered; in the hospital setting where the test is used to support infection control and treatment decisions among patients being admitted to hospital with respiratory symptoms, and in the community setting where the test is used in decentralized community clinics to identify cases of COVID-19 who should self-isolate. The authors extend their approach across countries by consulting experts from India, Nigeria, South Africa, and Brazil. They demonstrate that an antigen-detection rapid diagnostic test-led strategy is likely to improve health outcomes and be more inexpensive than a strategy based on nucleic acid tests and clinical judgment, in both hospital and community settings. Their approach is distinct from a conventional cost-effectiveness plane. The cost-effectiveness of SARS-CoV-2 diagnostic tests is a major global concern as well as the speed, accuracy, and simplicity of testing. Cost-effectiveness analysis facilitates evidence-based solutions for policymakers to prevent COVID-19 transmission. Silent transmission is also an important public health issue to control COVID-19. Approximately 50% of transmissions occur from asymptomatic or presymptomatic persons [5, 6] . In the future, an economic evaluation of public health strategies for patients and residents, including asymptomatic and presymptomatic persons with risk assessments, will become more critical. Public health strategies may be a combination of several effective preventive methods and diagnostic tests for high-risk groups and contacts [7, 8] . Ricks et al.'s research strongly suggests that policymakers could choose COVID-19 antigen detection tests to control COVID-19 instead of nucleic acid tests for symptomatic persons, based on evidence, even with some limitations in the infectivity and transmission dynamics of SARS-CoV2 in the modelling analysis [4] . To make public health decisions that maximize health benefits for the largest number of patients and residents with limited resources, we need the continuous challenge to evaluate the cost-effectiveness and feasibility of novel SARS-CoV-2 diagnostic methods. COVID-19 diagnosis -a review of current methods Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infection Quantifying the potential value of antigen-detection rapid diagnostic 1 tests for COVID-19: a modelling analysis Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility The implications of silent transmission for the control of COVID-19 outbreaks Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening. Sci Adv Imperial College COVID-19 Response Team. Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations The author declares that they have no competing interests.